Author Topic: Decreased prevalence of cancer in patients with MS--a case-control study  (Read 171 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
Articles pointing toward a decreased risk of cancer in persons with MS have been posted on this board in the past, and this one is from PLoS One, November 27, 2017:

Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
You can pick your studies because if there's one showing one finding, you're probably going to find another one showing something quite different. Here's a study finding an increased risk of cancer among patients with MS and their relatives.


From PubMed (October 3, 2019),"Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study":


https://www.ncbi.nlm.nih.gov/pubmed/31573834
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
146 Views
Last post March 04, 2019, 09:36:37 pm
by agate
0 Replies
110 Views
Last post May 12, 2019, 12:29:08 pm
by agate
0 Replies
88 Views
Last post August 01, 2019, 07:27:51 am
by agate
0 Replies
80 Views
Last post June 27, 2020, 08:54:06 pm
by agate
0 Replies
18 Views
Last post January 21, 2022, 09:23:40 pm
by agate